Searched for
SUN PHARMAQ2
Eicher Motors Q4 Results: Cons profit grows 12% YoY to Rs 1,520 crore, revenue jumps 16%Eicher Motors, the maker of Royal Enfield, posted a 12% rise in net profit for the March quarter of FY26. The company's revenue also saw a ...- Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividendSun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while re...
- Sun Pharma shares in focus after muted Q2 earnings. Nuvama maintains hold with Rs 1,800 targetSun Pharma will be in focus after reporting a Q2 FY26 net profit of Rs 3,117.95 crore, up 2.6% YoY, with revenue rising 8.6% to Rs 14,405 c...
- Sun Pharma Q2 Results: Cons profit up 3% YoY to Rs 3,118 crore, revenue rises 9%Sun Pharmaceutical Industries reported a net profit of Rs 3,117.95 crore for Q2 FY26, a 2.6% year-on-year increase. Revenue from operations...
- Sun Pharma Q2 Preview: PAT may rise 2% YoY; Leqselvi spending to weigh on marginsSun Pharma is expected to report modest Q2 FY26 earnings growth, with PAT likely up 2% YoY and revenue rising 7%. Analysts cite Leqselvi la...
- Sun Pharma shares tumble 2% despite Q2 profit rising 28% YoY to Rs 3,040 crore. Should you invest?Sun Pharma Share Price: Sun Pharmaceuticals' shares fell by 2% despite a strong financial performance in the second quarter. The company re...
- Sun Pharma Q2 Results: Profit rises 28% YoY to Rs 3,040 crore, beats estimatesSun Pharmaceutical Q2 FY25 Results: Sun Pharma reported a 28% increase in consolidated net profit for Q2, reaching Rs 3,040 crore, up from ...
- Sun Pharma Q2 Results Preview: PAT may rise 25% YoY; healthy revenue growth seenRevenue from operations is likely to jump 10% year-on-year, according to the average estimate of four brokerages. Meanwhile, net profit for...
- Sun Pharma Q2 Results: Net profit rises 5% YoY to Rs 2,376 croreThe earnings for interest, tax, depreciation and ammortisation (EBITDA) rose 7.5% to Rs. 3179.4 crore in Q2, and EBITDA margins declined 90...
- Sun Pharma Q2 Results: Cons profit rises 6% YoY to Rs 2,385 crore, beats estimatesOperating profit, calculated as earnings before interest, taxes, depreciation, and amortization (EBITDA), for the quarter, rose nearly 8% o...
- Sun Pharma Q2 Results: Profit rises 8% YoY to Rs 2,260 crore as revenue jumps 14%The pharma major's profit was higher than ET Now poll estimate of Rs 2,040 crore. However, revenue was below the expected figure of Rs 11,0...
- Sun Pharma Q2 Preview: Higher costs, price erosion to mar profitabilityThe operational performance, however, will be hit by higher research and development costs, input prices, and continued erosion in prices i...
- Sun Pharma CFO on what led to the growth in Indian and US businesses“Sun Pharma expects to gain momentum and continue to focus on building the prescriptions for core specialty products.”
- Sun Pharma Q2 takeaways: Debt comes down, R&D spends increase & moreAnalysts believe the performance will give a boost to shares of the company that have seen undeserving selling.
- Sun Pharma Q2 Results: Net profit jumps 70% to Rs 1,813 crore, beats St estimatesSun Pharma shares traded 2.78 per cent higher at Rs 482.25 after the announcement of its quarterly results.
- Q2 preview: Sun Pharma may report flat to single-digit profit growthPrabhudas Lilladher expects Sun Pharma to report a 7.1 per cent increase in net profit from a year ago, while it believes net sales may hav...
- Brokerages bullish on Sun Pharma, see up to 22% upsideSun Pharma’s net sales for the quarter rose 16.10 per cent to Rs 7,949.19 crore.
- Sun Pharma back in the black; key Q2 takeawaysSales in the US were $339 million for the quarter, flat over the same period last year.
- Sun Pharma posts Q2 profit of Rs 1,064 crore, meets Street estimatesThe drug maker had reported a loss of Rs 269.60 crore in the corresponding quarter last year.
- Sun Pharma reports surprise Q2 loss of Rs 219 crore on one-time hitAnalysts in an ET NOW poll had estimated a profit of Rs 975 crore.
Load More
